Whoop Raises $575M Series G with Abbott and Mayo Clinic Participationg post
Whoop has raised $575 million in a Series G round, valuing the wearable health tech company at $10.1 billion. The funding brings in strategic backers including Abbott and Mayo Clinic as Whoop expands its platform for health monitoring and disease prevention.
FUNDRAISE
Editor
4/2/20261 min read
Whoop, a Boston-based wearable health technology company, has raised $575 million in Series G financing at a $10.1 billion valuation. The round includes Abbott as a strategic investor, alongside Mayo Clinic.
The company develops wearable devices and a subscription-based health tracking platform focused on sleep, recovery, strain, fitness, and longevity. Its product offers a 14-day battery life and includes features such as FDA-cleared ECG capabilities, blood pressure insights, a Healthspan feature focused on longevity, and Advanced Labs for blood biomarker analysis.
Whoop said it will use the new capital to accelerate development of its AI-powered platform, with the stated goal of helping predict and prevent disease. The company announced the financing on April 1, 2026.
Abbott’s participation is notable given its position in continuous glucose monitoring. The investment adds to a broader pattern of activity between medical device companies and consumer health tracking platforms, as players across the sector look to expand more personalized and continuous health monitoring.